Abstract:Background: Microbes have been implicated in atherosclerosis development and progression, but the impact of bacterial-based biofilms on fibrous plaque rupture remains poorly understood. Results: Here, we developed a comprehensive atherosclerotic model to reflect the progression of fibrous plaque under biofilm-induced inflammation (FP-I). High expressions of biofilm-specific biomarkers algD, pelA and pslB validated the presence of biofilms. Biofilm promotes the polarization of macrophages to-wards a pro-inflammatory (M1) phenotype, as demonstrated by an increase in M1 macrophage-specific marker CD80 expression in CD68+ macrophages. The increase in the number of intracellular lipid droplets (LDs) and foam cell percentage highlighted the potential role of biofilms on lipid synthesis or metabolic pathways in macrophage-derived foam cells. In addition, collagen I production by myofibroblasts associ-ated with the fibrous cap was significantly reduced along with the promotion of apoptosis of myofibrob-lasts, indicating that biofilms affect the structural integrity of the fibrous cap and potentially undermine its strength. Conclusion: We validated the unique role of biofilm-based inflammation in exacerbating fibrous plaque damage in the FP-I model, increasing fibrous plaque instability and risk of thrombosis. Our results lay the foundation for mechanistic studies of the role of biofilms in fibrous plaques, allowing the evaluation of preclinical combination strategies for drug therapy. Statement of significance A microsystem-based model was developed to reveal interactions in fibrous plaque during biofilm-induced inflammation (FP-I). Real-time assessment of biofilm formation and its role in fibrous plaque progression was achieved. The presence of biofilms enhanced the expression of pro-inflammatory (M1) specific marker CD80, lipid droplets, and foam cells and reduced anti-inflammatory (M2) specific marker CD206 expression. Fibrous plaque exposure to biofilm-based inflammation reduced collagen I expression and increased apoptosis marker Caspase-3 expression significantly. Overall, we demonstrate the unique role of biofilm-based inflammation in exacerbating fibrous plaque damage in the FP-I model, promoting fibrous plaque instability and enhanced thrombosis risk. Our findings lay the groundwork for mechanistic studies, facilitating the evaluation of preclinical drug combination strategies.& COPY; 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS

Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.

Pro-inflammatory Effect of Fibrinogen on Vascular Smooth Muscle Cells by Regulating the Expression of PPARα, PPARγ and MMP-9

Homocysteine Stimulates Nuclear Factor Κb Activity and Interleukin-6 Expression in Rat Vascular Smooth Muscle Cells

Pravastatin inhibits fibrinogen‑ and FDP‑induced inflammatory response via reducing the production of IL‑6, TNF‑α and iNOS in vascular smooth muscle cells

[Effect of Fibrinogen, Fibrin and Fibrin (ogen) Degradation Products on the Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Expressions of Vascular Endothelial Cells in Coculture System].

C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells

Fibrinopeptide A Induces Expression of C-Reactive Protein Via the ROS-ERK1/2/ P38-NF-κB Signal Pathway in Vascular Smooth Muscle Cells

Cytokines and atherosclerosis: a comprehensive review of studies in mice

Pravastatin inhibits C-reactive protein generation induced by fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle cells

The Effect of Interleukin1β and Tumor Necrosis Factor Α on Expression of Acyl-Coa Cholesterol Acyltransferase Enzyme Mrnain Vascular Smooth Muscle Cells and Foam Cells

The NF- κ B pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs

Fibrinopeptide A Induces C‐reactive Protein Expression Through the ROS‐ERK1/2/p38‐NF‐κB Signal Pathway in the Human Umbilical Vascular Endothelial Cells

C-reactive Protein-Induced Expression of CD40-CD40L and the Effect of Lovastatin and Fenofibrate on It in Human Vascular Endothelial Cells.

Fibrin-derived Peptide Bβ15-42 and Earthworm Fibrinolytic Enzyme A Inhibit Atherosclerosis and Inflammation via the VE-cadherin Pathway

Palmitic Acid Exerts Pro-Inflammatory Effects on Vascular Smooth Muscle Cells by Inducing the Expression of C-reactive Protein, Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-Α.

Biofilms Exacerbate Atherogenesis Through Macrophage-Induced Inflammatory Responses in a Fibrous Plaque Microsystem Model.

Effects of the Factor Xa Inhibitor, Fondaparinux, on the Stability of Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice

C-Reactive Protein-Induced Expression Of Cd40-Cd40l And The Effect Of Lovastatin And Fenotibrate On It In Human Vascular Endothelial Cells

Fibronectin and Artherosclerosis

Fibrinogen as a key regulator of inflammation in disease